TwinStrand Biosciences
Gunnar Nordquist is currently the Director of Finance at TwinStrand Biosciences since August 2021. Prior to that, worked at Adaptive Biotechnologies Corp. as a Financial Analyst II from June 2020 to August 2021. Before that, Gunnar was a Finance Planning Analyst II at Advanced Sterilization Products (ASP) from April 2019 to June 2020. Gunnar also held roles at Fortive as a Senior Transfer Pricing Analyst and Transfer Pricing Analyst from July 2016 to March 2019. Gunnar achieved a Master of Business Administration (MBA) from Washington State University in 2016 and a Bachelor of Arts (BA) in Finance in 2012.
TwinStrand Biosciences
4 followers
TwinStrand Biosciences is a Seattle genomics company building a platform around Duplex Sequencing, a proprietary process that helps physicians, patients and drug researchers make life saving decisions faster based on DNA data.